IMGN

ImmunoGen, Inc.

1 day chart

About IMGN

ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company’s technology comprises an antibody that binds to a target found on tumor cells and is conjugated to one of its potent anti-cancer agents as a payload to kill the tumor cell once the ADC has bound to its target. Its ELAHERE (Mirvetuximab Soravtansine) is a first-in-class ADC targeting folate receptor alpha (FRa), a cell-surface protein over-expressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Its Pivekimab sunirine (PVEK), is an ADC comprised of a high-affinity antibody designed to target CD123 with site-specific conjugation. The Company is advancing PVEK in clinical trials for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) and acute myeloid leukemia (AML).

Buy US stocks in Australia starting with IMGN. Open an account and start investing today!

Market Capitalisation

$3.44B

Price-earnings ratio

Dividend yield

0.00%

Volume

105

High today

$14.16

Low today

$13.24

Open price

$0.00

52-week high

$14.91

52-week low

$3.10

IMGN FAQs

Can I buy IMGN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy IMGN shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of ImmunoGen, Inc.?

One share of ImmunoGen, Inc. is valued at $13.46.

What is the ticker symbol for ImmunoGen, Inc.?

The ticker symbol for ImmunoGen, Inc. is IMGN.

How do I buy IMGN shares in Australia?

To buy IMGN stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in IMGN

What is the 52-week high for ImmunoGen, Inc. stock?

The ImmunoGen, Inc. 52-week high stock price is $14.91.

What is the 52-week low for ImmunoGen, Inc. stock?

The ImmunoGen, Inc. 52-week low stock price is $3.10.

What is the market capitalisation of ImmunoGen, Inc. IMGN?

As of 31/05/2023 ImmunoGen, Inc. has a market cap of $3.4B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.